SUN-777 CALIBRATE-PEDS: A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants with Autosomal Dominant Hypocalcemia Type1
Peter J. Tebben(Yale University), Rachel I. Gafni(National Institutes of Health), R. Todd Alexander(University of Alberta), Stefano Mora(Vita-Salute San Raffaele University), Scott A. Adler(Bridge Pharma (United States)), Mary Scott Roberts(Bridge Pharma (United States)), Raja Padidela(Manchester Academic Health Science Centre), Dingfeng Li(University of Science and Technology of China)
Cited by 0
Related Papers
The landscape of aging
|Science China Life Sciences|2022|411
Biomarkers of aging
|Science China Life Sciences|2023|362
Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study
|The Lancet Diabetes & Endocrinology|2020|317
Calcium and phosphate homeostasis: Concerted interplay of new regulators
|Annals of Medicine|2008|262